Period2 deficiency blunts hypoxia-induced mobilization and function of endothelial progenitor cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Qin, Tao ^b   Sun, Yuan Yuan ^a,b   Bai, Wen Wu ^b   Wang, Bo ^b   Xing, Yi Fan ^b   Liu, Yan ^a   Yang, Rui Xue ^a   Zhao, Yu Xia ^b   Li, Jian Min ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; CIRCADIAN RHYTHM SIGNALING PROTEIN; PER2 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CAPILLARY DENSITY; CELL COUNT; CELL FUNCTION; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; GENE FUNCTION; GENE LOSS; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NONHUMAN; PERIOD2 GENE; PROTEIN EXPRESSION; REGULATOR GENE; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; PERIOD CIRCADIAN PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84907487954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108806     Document Type: Article

References (50)

1. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779.
2. Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, et al. (2004) llllnlabeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45:512-518.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228.
4. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, et al. (2006) VEGF and PIGE promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20: 1495-1497.
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
6. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, et al. (2005) Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26: 1196-1204.
7. Prasad A, Stone GW, Stuckey TD, Costandni CO, Zimetbaum PJ, et al. (2005) Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 45: 508-514.
8. Shantsila E, Watson T, Lip GY (2007) Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49: 741-752.
9. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, et al. (2007) Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 49: 2341-2349.
10. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
11. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, et al. (2007) Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 191: 115-120.
12. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al. (2001) Neovascularization of ischemic myocardium by human bonemarrow- derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430 -436.
13. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199.
14. Hansen J, Lassen CF (2014) Shift work and risk of cancer and coronary heart diseases. Ugeskr Laeger 176: 146-149.
15. Sato M, Matsuo T, Atmore H, Akashi M (2014) Possible contribution of chronobiology to cardiovascular health. Front Physiol 4: 409.
16. Maemura K (2013) Circadian rhythm and ischemic heart disease. Nihon Rinsho 71: 2124-2129.
17. Pan X, Jiang XC, Hussain MM (2013) Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice. Circulation 128: 1758-1769.
18. Muller JE (1999) Circadian variation and triggering of acute coronary events. Am Heart J 137: S1-S8.
19. Lamont EW, James FO, Boivin DB, Cermakian N (2007) From circadian clock gene expression to pathologies. Sleep Med 8: 547-556.
20. Yue X, Yu H, Lin X, Liu K, Wang X, et al. (2013) Investigation into the optimal surgical conditions for coronary artery ligation for establishing a myocardial infarction model in mice. Exp Ther Med 6: 341-346.
21. Kido M, Du L, Sullivan CC, Li X, Deutsch R, et al. (2005) Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 46: 2116-2124.
22. Eirin A, Zhu XY, Woollard JR, Herrmann SM, Gloviczki ML, et al. (2013) Increased circulating inflammatory endothelial cells in blacks with essential hypertension. Hypertension 62: 585-591.
23. Riegersperger M, Plischke M, Steiner S, Seidinger D, Sengoelge G, et al. (2013) Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation 95: 1338 -1345.
24. Massot A, Navarro-Sobrino M, Penalba A, Arenillas JF, Girait D, et al. (2013) Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts. Cerebrovasc Dis 35: 81-88.
25. Krishnamurthy P, Thai M, Yerma S, Hoxha E, Lambers E, et al. (2011) Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 109: 1280-1289.
26. Heeschen C, Aicher A, Lehmann R, Fichdscherer S, Vasa M, et al. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346.
27. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, et al. (2002) Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30: 967-972.
28. Kuliczkowski W, Derzhko R, Prajs I, Podolak-Dawidziak M, Serebruany VL (2012) Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions. Am J Ther 19: 44-50.
29. Antonio N, Fernandes R, Soares A, Soares F, Lopes A, et al. (2014) Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycmie continuum. Cardiovasc Diabetol 13: 101.
30. Porto I, De Maria GL, Leone AM, Dato I, D'Amario D, et al. (2013) Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 112: 782-791.
31. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, et al. (2003) Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121.
32. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117: 1249 -1259.
33. Nakajima M, Ogawa M, Shimoda Y, Hiraoka S, Iida M, et al. (2006) Presenilin1 1 the growth and differentiation of endothelial progenitor cells through its beta-catenin-binding region. Cell Biol Int 30: 239-243.
34. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
35. Sun YY, Bai WW, Wang B, Lu XT, Xing YE, et al. (2014) Period 2 is essential to maintain early endothelial progenitor cell function in vitro and angiogenesis after myocardial infarction in mice. J Cell Mol Med 18: 907-918.
36. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779.
37. Wang CY, Wen MS, Wang HW, Hsieh IC, Li Y, et al. (2008) Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. circulation 118:2166-2173.
38. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-637.
39. Moon SK, Cha BY, Kim CH (2004) ERK1/2 mediates TNF-alpha-̄nduced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 198:417-427.
40. Chung TW, Lee YC, Kim CH (2004) Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/ AKT pathways: involvement of invasive potential. FASEBJ 18:1123-1125.
41. Tanimura S, Asato K, Fujishiro SH, Kohno M (2003) Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down- regulation of matrix metalloproteinase-3/-9/-14 and CD44. Biochem Biophys Res Commun 304:801-806.
42. Zhou J, Cheng M, Liao YH, Hu Y, Wu M, et al. (2013) Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells. PLoS One 8:e63126.
43. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological revascularization. Circ Res 85:221-228.
44. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
45. Po-Hsun Huang, Yung-Hsiang Chen, Chao-Hung Wang, Jia-Shiong Chen, Hsiao-Ya Tsai (2009) Matrix Metalloproteinase-9 Is Essential for IschemiaInduced Neovascularization by Modulating Bone Marrow -Derived Endothelial Progenitor Cells. Arterioscler Thromb Vase Biol 29:1179-1184.
46. Hoffmann BR, Wagner JR, Prisco AR, Janiak A, Greene AS (2013) Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxia stress. Physiol Genomics 45:1021 -1034.
47. Kanzler I, Tuchscheerer N, Steffens G, Simsekyilmaz S, Konschalla S, et al. (2013) Differential role of angiogenic chemokines in endothelial progenitor cellinduced angiogenesis. Basic Res Cardiol 108:310.
48. Yao Y, Sheng Z, Li Y, Yan F, Eu C, et al. (2012) Tissue Kallikrein Promotes Cardiac Neovascularization by Enhancing Endothelial Progenitor Cell Functional Capacity. HUMAN GENE THERAPY 23:859-870.
49. Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, et al. (2012) Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch critical for myocardial adaptation to ischemia. Nat Med 18: 774-782.
50. LlevadotJ, Murasawa S, Kureishi Y, Uchida S, Masuda H, et al. (2001) HMGCoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108: 399-405.